Page last updated: 2024-10-31

methyl methanesulfonate and Carcinoma, Transitional Cell

methyl methanesulfonate has been researched along with Carcinoma, Transitional Cell in 2 studies

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research Excerpts

ExcerptRelevanceReference
"However, in three MMS-treated animals the hyperplasias had progressed to well-differentiated transitional-cell carcinomas."1.27The induction of urothelial hyperplasia by methyl methanesulphonate and ethyl methanesulphonate. ( Hicks, RM; Severs, NJ; Tudor, RJ, 1983)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tudor, RJ2
Severs, NJ2
Hicks, RM2

Other Studies

2 other studies available for methyl methanesulfonate and Carcinoma, Transitional Cell

ArticleYear
The "promoting" activity of methyl methanesulphonate in rat bladder carcinogenesis.
    British journal of cancer, 1984, Volume: 50, Issue:1

    Topics: Animals; Carcinoma, Transitional Cell; Cocarcinogenesis; Drug Synergism; Female; Hyperplasia; Methyl

1984
The induction of urothelial hyperplasia by methyl methanesulphonate and ethyl methanesulphonate.
    British journal of cancer, 1983, Volume: 48, Issue:2

    Topics: Animals; Carcinoma, Transitional Cell; Dose-Response Relationship, Drug; Ethyl Methanesulfonate; Fem

1983